JPRN-UMIN000029534已完成未知
Study of patient risk factors for febrile neutropenia in NHL receiving (R)CHOP regimen 2 - STOP FN in NHL 2
The Cancer Institute Hospital Of JFCR0 个研究点目标入组 239 人开始时间: 2017年10月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 239
研究概览
简要总结
Refer to the article
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •HIV related NH
研究者
相似试验
已完成
不适用
Study Of Patient risk factors for Febrile Neutropenia in NHL patients receiving (R)CHOP regimeon Hodgkin's LymphomaJPRN-UMIN000015121The Cancer Institute Hospital Of JFCR400
招募中
不适用
IL-8 study.- Pediatric cancer patients- Febrile neutropenia- Risk assessment model- Antibiotic treatmentNL-OMON21368niversity Medical Center of GroningenHanzeplein 19713 GZ Groningen270
已完成
不适用
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.Chemotherapy-induced Febrile NeutropeniaNCT01813721Amgen1,007
已完成
不适用
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic ChemotherapyBreast CancerOvarian CancerNon-Small Cell Lung CancerSmall Cell Lung CancerNCT00883181Amgen1,370
已完成
不适用
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical ProtocolSquamous Cell Head and Neck CarcinomaNCT01268878Groupe Oncologie Radiotherapie Tete et Cou130